Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Advances in the use of topical imiquimod to treat dermatologic disorders
Giuseppe Micali
Therapeutics and Clinical Risk Management (2008) Vol. Volume 4, pp. 87-97
Open Access | Times Cited: 40

Showing 1-25 of 40 citing articles:

Aldara activates TLR7-independent immune defence
Anne Walter, Mathias Schäfer, Virginia Cecconi, et al.
Nature Communications (2013) Vol. 4, Iss. 1
Open Access | Times Cited: 240
Development of nanovesicular systems for dermal imiquimod delivery: physicochemical characterization and in vitro/in vivo evaluation
Man Ma, Jinping Wang, Fang Guo, et al.
Journal of Materials Science Materials in Medicine (2015) Vol. 26, Iss. 6
Closed Access | Times Cited: 121
Topical pharmacotherapy for skin cancer
Giuseppe Micali, Francesco Lacarrubba, Maria Rita Nasca, et al.
Journal of the American Academy of Dermatology (2014) Vol. 70, Iss. 6, pp. 979.e1-979.e12
Closed Access | Times Cited: 102
Imiquimod - Its role in the treatment of cutaneous malignancies
AdityaKumar Bubna
Indian Journal of Pharmacology (2015) Vol. 47, Iss. 4, pp. 354-354
Open Access | Times Cited: 99
Lactobacillus pentosus GMNL-77 inhibits skin lesions in imiquimod-induced psoriasis-like mice
Yi‐Hsing Chen, Chieh‐Shan Wu, Ya-Husan Chao, et al.
Journal of Food and Drug Analysis (2016) Vol. 25, Iss. 3, pp. 559-566
Open Access | Times Cited: 97
Topical pharmacotherapy for skin cancer
Giuseppe Micali, Francesco Lacarrubba, Maria Rita Nasca, et al.
Journal of the American Academy of Dermatology (2014) Vol. 70, Iss. 6, pp. 965.e1-965.e12
Closed Access | Times Cited: 76
Adaptors in Toll-Like Receptor Signaling and their Potential as Therapeutic Targets
Thomas Ve, Nicholas J. Gay, Ashley Mansell, et al.
Current Drug Targets (2012) Vol. 13, Iss. 11, pp. 1360-1374
Closed Access | Times Cited: 74
Towards therapeutic advances in melanoma management: An overview
Swarnendra Singh, Atif Zafar, Shahper N. Khan, et al.
Life Sciences (2017) Vol. 174, pp. 50-58
Closed Access | Times Cited: 52
Intradermal delivery of imiquimod using polymeric microneedles for basal cell carcinoma
Akmal Hidayat Bin Sabri, Zachary Cater, Pratik Gurnani, et al.
International Journal of Pharmaceutics (2020) Vol. 589, pp. 119808-119808
Open Access | Times Cited: 44
Imiquimod in the treatment of penile intraepithelial neoplasia: An update
Kristyn Deen, D. Burdon‐Jones
Australasian Journal of Dermatology (2016) Vol. 58, Iss. 2, pp. 86-92
Closed Access | Times Cited: 46
Nonspecific genital ulcers
Virendra Sehgal, Deepika Pandhi, Ananta Khurana
Clinics in Dermatology (2014) Vol. 32, Iss. 2, pp. 259-274
Closed Access | Times Cited: 42
Treating skin cancer with topical cream
Giuseppe Micali, Francesco Lacarrubba, Franco Dinotta, et al.
Expert Opinion on Pharmacotherapy (2010) Vol. 11, Iss. 9, pp. 1515-1527
Closed Access | Times Cited: 45
Induction of vitiligo after imiquimod treatment of condylomata acuminata
Wenfei Li, Hongyan Xin, Lingzhi Ge, et al.
BMC Infectious Diseases (2014) Vol. 14, Iss. 1
Open Access | Times Cited: 35
NLRP1 Inflammasome Activation in Keratinocytes: Increasing Evidence of Important Roles in Inflammatory Skin Diseases and Immunity
Gabriele Fenini, Tugay Karakaya, Paulina Hennig, et al.
Journal of Investigative Dermatology (2022) Vol. 142, Iss. 9, pp. 2313-2322
Open Access | Times Cited: 17
The ophthalmic side-effects of imiquimod therapy in the management of periocular skin lesions
Paul S. Cannon, B. O'Donnell, Shyamala C. Huilgol, et al.
British Journal of Ophthalmology (2010) Vol. 95, Iss. 12, pp. 1682-1685
Closed Access | Times Cited: 38
Mice Lacking MSK1 and MSK2 Show Reduced Skin Tumor Development in a Two-Stage Chemical Carcinogenesis Model
Simon Chang, Lars Iversen, Knud Kragballe, et al.
Cancer Investigation (2011) Vol. 29, Iss. 3, pp. 240-245
Closed Access | Times Cited: 34
A comparative study of 10% KOH solution and 5% imiquimod cream for the treatment of Molluscum contagiosum in the pediatric age group
Namitha Chathra, D Sukumar, RameshM Bhat, et al.
Indian Dermatology Online Journal (2015) Vol. 6, Iss. 2, pp. 75-75
Open Access | Times Cited: 23
Infrared imaging spectroscopy and chemometric tools for in situ analysis of an imiquimod pharmaceutical preparation presented as cream
Renato Lajarim Carneiro, Ronei J. Poppi
Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy (2013) Vol. 118, pp. 215-220
Closed Access | Times Cited: 23
Perianal Basal Cell Carcinoma—A Systematic Review and Meta-Analysis of Real-World Data
Tzong-yun Tsai, Chun‐Kai Liao, Bang‐Yan Zhang, et al.
Diagnostics (2023) Vol. 13, Iss. 9, pp. 1650-1650
Open Access | Times Cited: 6
Medical approaches to non-melanoma skin cancer
Giuseppe Micali, Francesco Lacarrubba, Karishma Bhatt, et al.
Expert Review of Anticancer Therapy (2013) Vol. 13, Iss. 12, pp. 1409-1421
Closed Access | Times Cited: 22
Comparative study for the effect of photodynamic therapy, imiquimod immunotherapy and combination of both therapies on 40 lesions of actinic keratosis in Japanese patients
Noriko Tanaka, Chika Ohata, Norito Ishii, et al.
The Journal of Dermatology (2013) Vol. 40, Iss. 12, pp. 962-967
Closed Access | Times Cited: 17
Lmax and imiquimod 3.75%: the new standard in AK management
Eggert Stockfleth
Journal of the European Academy of Dermatology and Venereology (2014) Vol. 29, Iss. s1, pp. 9-14
Closed Access | Times Cited: 16
The Efficacy of Imiquimod on Dysplastic Lesions of the Oral Mucosa: An Experimental Model
Vasiliki Gkoulioni, Anna Eleftheriadou, Ioannis Yiotakis, et al.
Anticancer Research (2010) Vol. 30, Iss. 7, pp. 2891-2896
Closed Access | Times Cited: 19
Safety, efficacy & recurrence rates of imiquimod cream 5% for treatment of anogenital warts.
M L Diamantis, B L Bartlett, Stephen K. Tyring
PubMed (2009) Vol. 14, Iss. 5, pp. 1-3, 5
Closed Access | Times Cited: 15
Topical Antineoplastic Agents in the Treatment of Mucocutaneous Diseases
Anna L. Grossberg, Anthony A. Gaspari
Current problems in dermatology (2011), pp. 71-82
Closed Access | Times Cited: 13
Page 1 - Next Page

Scroll to top